Synlett 2008(8): 1155-1158  
DOI: 10.1055/s-2008-1072715
LETTER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Novel Bicyclic Nitroxides Using Partial Favorskii Rearrangement

Andrej Babič*a, Slavko Pečara,b
a Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia
Fax: +386(1)4258031; e-Mail: andrej.babic@ffa.uni-lj.si;
b Jo˛ef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia
Further Information

Publication History

Received 24 January 2008
Publication Date:
16 April 2008 (online)

Abstract

3-Bromo-2,2,6,6-tetramethyl-4-oxopiperidine-1-oxyl was reacted with several C-nucleophiles to give novel bicyclic pyrrolidine nitroxides through partial Favorskii rearrangement. Further reduction with sodium borohydride gave spin probes with free hydroxyl groups and under harsh reduction conditions allowed the Favorskii rearrangement to proceed to completion.

    References and Notes

  • 1 Kende AS. The Favorskii Rearrangement of Haloketones, In Organic Reactions   Vol. 2:  John Wiley and Sons; New York: 1960.  p.261 
  • 2 De Kimpe N. Verhe R. Buyck L. Moens L. Schamp N. Tetrahedron Lett.  1981,  22:  1837 
  • 3 Nagasawa HT. Elberling JA. Tetrahedron Lett.  1969,  44:  5393 
  • 4 Rozantzev EG. Free Nitroxyl Radicals   Plenum Press; New York: 1970.  p.204 
  • 5 Volodarsky LB. Reznikov VA. Ovacharenko VI. Synthetic Chemistry of Stable Nitroxides   40:  CRC Press; Boca Raton: 1994.  p.89 
  • 6 Hankovszky OH. Hideg K. Bódi I. Frank L. J. Med. Chem.  1986,  29:  1138 
  • 7 Rozantzev EG. Krinitzkaya LA. Tetrahedron  1965,  21:  491 
  • 8 Elas M. Williams BB. Parasca A. Mailer C. Pelizzari CA. Lewis MA. River JN. Karczmar GS. Barth ED. Halpern HJ. Magn. Reson. Med.  2003,  49:  682 
  • 9 Shen J. Liu S. Miyake M. Liu W. Pritchard A. Kao JPY. Rosen GM. Tong Y. Liu KJ. Magn. Reson. Med.  2006,  55:  1433 
  • 10 Kao JPY. Barth ED. Burks SR. Smithback P. Mailer C. Ahn K.-H. Halpern HJ. Rosen GM. Magn. Reson. Med.  2007,  58:  850 
  • 11 Berliner LJ. Spin Labeling   Academic Press; New York: 1976.  p.274 
  • 12 Marc G. Pečar S. Synth. Commun.  1995,  25:  1015 
  • 13 Sosnovsky G. Cai Z. J. Org. Chem.  1995,  60:  3414 
  • 14 Sakai T. Amano E. Kawabata AA. Takeda A. J. Org. Chem.  1980,  45:  43 
  • 15 Sakai T. Katayama T. Takeda A. J. Org. Chem.  1981,  46:  2924 
  • 16 Sakai T. Tabata H. Takeda A. J. Org. Chem.  1983,  48:  4618 
  • 17 Barbee TR. Hedeel G. Heeg MJ. Albizati KF. J. Org. Chem.  1991,  56:  6773 
  • 18 De Angelis F. Feroci M. Inesi A. Bull. Soc. Chim. Fr.  1993,  130:  712 
  • 19 Rappe C. Knutsson L. Turro NJ. Gagosian RB. J. Am. Chem. Soc.  1970,  92:  2032 
  • 20 House HO. Frank GA. J. Org. Chem.  1965,  30:  2948 
  • 21 Becker HGO. Organikum   Wiley-VCH; Weinheim: 2001.  p.608 
22

Typical Procedure for the Synthesis of Products 6a-h
3-Bromo-2,2,6,6-tetramethyl-1-oxyl-piperidine-4-one (1, 400 mg, 1.61 mmol) was dissolved in anhyd THF (20 mL). The sodium salt of the appropriate C-nucleophile was dissolved in anhyd THF (5 mL) and added dropwise to the stirred solution of 1 over a period of 5 min under argon. The reaction mixture was refluxed at 50 °C for 1.5 h. After that time the solvent was evaporated under reduced pressure and the yellow solid dissolved in cold citric acid (10 mL, pH 3.5). The aqueous phase was immediately extracted with EtOAc. The organic phase was washed with brine, dried with Na2SO4, and the solvent evaporated under reduced pressure. The crude product was purified using circular chromatography (Et2O-hexane, 3:1). A bright yellow solid was obtained.

23

Methyl 2-Cyano-2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}acetate (6g) Yield 37%; yellow solid; mp 120-124 °C. IR (KBr): 3213, 2984, 2257, 1738, 1442, 1306, 1220, 1016, 928, 712 cm-1. MS (EI): m/z = 267 [M]+. 1H NMR (300 MHz, CDCl3): δ = 1.28 (s, 2 H, CH), 1.32 (s, 12 H, CH3), 3.30 (s, 1 H, CH), 3.84 (s, 3 H, COOCH3) ppm. EPR: aN = 1.55 mT. Anal. Calcd for C13H19N2O4 (%): C, 58.41; H, 7.19; N, 10.48. Found: C, 58.17; H, 7.33; N, 10.71.

24

Dimethyl 2-{6-Hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl} Malonate (6e) Yield 75%; yellow solid; mp 146-150 °C. IR (KBr): 3442, 2981, 1742, 1438, 1253, 1179, 1011, 914, 715, 624 cm-1. MS (EI): m/z = 300 [M]+. 1H NMR (300 MHz, CDCl3): δ = 1.21 (s, 12 H, CH3), 1.30 (s, 2 H, CH), 3.15 (s, 1 H, CH), 3.67 (s, 6 H, COOCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 23.21, 25.36, 31.58, 52.89, 58.09, 61.71, 65.92, 168.32 ppm. EPR: aN = 1.55 mT. Anal. Calcd for C14H22NO6 (%): C, 55.98; H, 7.38; N, 4.66. Found: C, 55.78; H, 7.57; N, 4.69.

25

NMR spectra were obtained after reduction with phenyl hydrazine. The compound was dissolved in perdeuterated solvent, transferred into a NMR tube, and flushed with argon. Phenyl hydrazine (2 equiv) was added and the NMR tube shaken to allow the reduction to proceed to completion prior to the NMR spectroscopic analysis.

26

Preparation of tert -Butyl 3-Hydroxy-2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl)butanoate} (8) tert-Butyl 2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}-3-oxobutanoate (6c) (200 mg, 0.61 mmol) was dissolved in MeOH (10 mL) and cooled to 0 °C. Sodium borohydride (24 mg, 0.61 mmol) was added with stirring. The temperature was maintained at 0 °C for 2 h, after which the reaction was quenched with citric acid and the pH adjusted to 6. The solvents were evaporated under reduced pressure and citric acid (10%) was added to adjust the pH to 3. The water phase was extracted with EtOAc. The organic phase was washed with brine, dried with Na2SO4, and the solvent evaporated under reduced pressure. The crude product was purified using circular chromatography (Et2O-hexane, 3:1). A bright yellow solid was obtained; yield 93%; mp 101-108 °C. IR (KBr): 3460, 2976, 1702, 1477, 1375, 1160, 993, 646 cm-1. MS (EI): m/z = 328 [M]+. MS-FAB: m/z = 330 [M + 2]+. HRMS (EI): m/z calcd for C17H30N1O5: 328.212398 [MH]+; found: 328.213250.

27

Preparation of 2-{6-Hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}-1-phenyl-propane-1,3-diol (7) Ethyl 2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}-3-oxo-3-phenylpropanoate (6f, 170 mg, 0.47 mmol) was dissolved in MeOH (10 mL) and cooled to 0 °C. While being stirred, NaBH4 (42 mg, 1.06 mmol) was added. The same amount of NaBH4 (42 mg, 0.53 mmol) was again added after 1 h and 2 h. After the third addition the reaction mixture was allowed to warm to ambient temperature. Then, 12 h later, citric acid was added and the pH adjusted to 6. The solvents were evaporated under reduced pressure and citric acid (10%) was added to adjust the pH to 3. The water phase was extracted with EtOAc. The organic phase was washed with brine, dried with Na2SO4, and the solvent evaporated under reduced pressure. The crude product was purified using circular chromatography (CH2Cl2-MeOH, 15:1). A bright yellow solid was obtained; yield 73%; mp 147-157 °C. IR (KBr): 3421, 2978, 1649, 1457, 1287, 1174, 1032, 705 cm-1. MS (EI): m/z = 320 [M]+. HRMS (EI): m/z calcd for C18H26N1O4: 320.186184 [MH+]; found: 320.187330.

28

Preparation of 1-(1-Oxyl-2,2,5,5-tetramethylpyrrolidine-3-yl)-2-hydroxymethyl-3-phenylpropane-1,3-diol (9a)
Ethyl 2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}-3-oxo-3-phenylpropanoate (6f, 300 mg, 0.83 mmol) was dissolved in THF (10 mL), and NaBH4 (148 mg, 3.72 mmol) was added. The reaction mixture was refluxed at 40 °C and MeOH (0.5 mL) was added over 0.5 h. Following the addition of MeOH the temperature was maintained at 40 °C for another 2.5 h. Several drops of H2O were then added and the solvents evaporated under reduced pressure, giving a bright yellow foam. Citric acid (10%, 10 mL) was added and the water phase extracted with EtOAc after the evolution of hydrogen stopped. The organic phase was washed with brine, dried with Na2SO4, and the solvent evaporated under reduced pressure. The crude product was purified using circular chromatography (CH2Cl2-MeOH, 15:1). A bright yellow solid was obtained; yield 21%; mp 157-163 °C. IR (KBr): 3290, 2976, 1474, 1411, 1367, 1295, 1257, 1050, 763, 706 cm-1. MS (EI): m/z = 322 [M]+. MS-FAB: m/z = 322 [M]+, 324 [M + 2]+. HRMS (EI): m/z calcd for C18H28N1O4: 322.201834 [M]+; found: 322.202650.